145 related articles for article (PubMed ID: 15566333)
1. Dengue vaccine: priorities and progress.
Guzmán MG; Muné M; Kourí G
Expert Rev Anti Infect Ther; 2004 Dec; 2(6):895-911. PubMed ID: 15566333
[TBL] [Abstract][Full Text] [Related]
2. Dengue vaccine design: issues and challenges.
Cardosa MJ
Br Med Bull; 1998; 54(2):395-405. PubMed ID: 9830205
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of susceptibility and transmissibility of the live, attenuated, candidate vaccines dengue-1 PDK13, dengue-3 PGMK30F3, and dengue-4 PDK48 after oral infection in Aedes aegypti.
Jirakanjanakit N; Khin MM; Yoksan S; Bhamarapravati N
Am J Trop Med Hyg; 1999 Oct; 61(4):672-6. PubMed ID: 10548309
[TBL] [Abstract][Full Text] [Related]
4. Dengue vaccine.
Simasathien S; Watanaveeradej V
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S363-77. PubMed ID: 16858980
[TBL] [Abstract][Full Text] [Related]
5. Infectivity of West Nile/dengue chimeric viruses for West Nile and dengue mosquito vectors.
Hanley KA; Goddard LB; Gilmore LE; Scott TW; Speicher J; Murphy BR; Pletnev AG
Vector Borne Zoonotic Dis; 2005; 5(1):1-10. PubMed ID: 15815144
[TBL] [Abstract][Full Text] [Related]
6. Development of new vaccines against dengue fever and Japanese encephalitis.
Kinney RM; Huang CY
Intervirology; 2001; 44(2-3):176-97. PubMed ID: 11509879
[TBL] [Abstract][Full Text] [Related]
7. Editorial: the challenge of dengue vaccine development and introduction.
Deen JL
Trop Med Int Health; 2004 Jan; 9(1):1-3. PubMed ID: 14728601
[No Abstract] [Full Text] [Related]
8. The first licensed dengue vaccine: an important tool for integrated preventive strategies against dengue virus infection.
Pitisuttithum P; Bouckenooghe A
Expert Rev Vaccines; 2016 Jul; 15(7):795-8. PubMed ID: 27171845
[No Abstract] [Full Text] [Related]
9. [Advances in the development of a vaccine against dengue].
Guzmán MG
Acta Cient Venez; 1998; 49 Suppl 1():38-45. PubMed ID: 10030053
[TBL] [Abstract][Full Text] [Related]
10. Dengue virus: molecular basis of cell entry and pathogenesis, 25-27 June 2003, Vienna, Austria.
Halstead SB; Heinz FX; Barrett AD; Roehrig JT
Vaccine; 2005 Jan; 23(7):849-56. PubMed ID: 15603884
[TBL] [Abstract][Full Text] [Related]
11. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
[TBL] [Abstract][Full Text] [Related]
12. Current status, challenges and perspectives in the development of vaccines against yellow fever, dengue, Zika and chikungunya viruses.
Silva JVJ; Lopes TRR; Oliveira-Filho EF; Oliveira RAS; Durães-Carvalho R; Gil LHVG
Acta Trop; 2018 Jun; 182():257-263. PubMed ID: 29551394
[TBL] [Abstract][Full Text] [Related]
13. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
[TBL] [Abstract][Full Text] [Related]
14. Dengue: recent advances in biology and current status of translational research.
Swaminathan S; Khanna N
Curr Mol Med; 2009 Mar; 9(2):152-73. PubMed ID: 19275624
[TBL] [Abstract][Full Text] [Related]
15. Developing a dengue vaccine: progress and future challenges.
Thomas SJ
Ann N Y Acad Sci; 2014 Sep; 1323():140-59. PubMed ID: 24689974
[TBL] [Abstract][Full Text] [Related]
16. Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.
Sun W; Nisalak A; Gettayacamin M; Eckels KH; Putnak JR; Vaughn DW; Innis BL; Thomas SJ; Endy TP
J Infect Dis; 2006 Jun; 193(12):1658-65. PubMed ID: 16703509
[TBL] [Abstract][Full Text] [Related]
17. Development of dengue vaccines: an overview.
Kanesa-thasan N
Indian Pediatr; 1998 Feb; 35(2):97-100. PubMed ID: 9707850
[No Abstract] [Full Text] [Related]
18. Evaluation of molecular strategies to develop a live dengue vaccine.
Lai CJ; Bray M; Men R; Cahour A; Chen W; Kawano H; Tadano M; Hiramatsu K; Tokimatsu I; Pletnev A; Arakai S; Shameem G; Rinaudo M
Clin Diagn Virol; 1998 Jul; 10(2-3):173-9. PubMed ID: 9741643
[TBL] [Abstract][Full Text] [Related]
19. Sculpting the immunological response to dengue fever by polytopic vaccination.
Zhou H; Deem MW
Vaccine; 2006 Mar; 24(14):2451-9. PubMed ID: 16417956
[TBL] [Abstract][Full Text] [Related]
20. [Dengue and dengue hemorrhagic fever: research priorities].
Guzmán MG; García G; Kourí G
Rev Panam Salud Publica; 2006 Mar; 19(3):204-15. PubMed ID: 16640849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
